GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Vanda Pharmaceuticals Inc. (VNDA) [hlAlert]

Rating:
Buy VNDA
up 2.91 %

Vanda Pharmaceuticals Inc. (VNDA) rated Buy with price target $20 by Jefferies & Co

Posted on: Wednesday,  Feb 17, 2010  11:25 AM ET by Jefferies & Co

Jefferies & Co rated Buy Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) on 02/17/2010. Previously Jefferies & Co rated Buy Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)
on 12/09/2009., when the stock price was $11.65. Since then, Vanda Pharmaceuticals Inc. has gained 2.92% as of 01/27/2016's recent price of $11.99.
If you would have followed the previous Jefferies & Co's recommendation on VNDA, you would have gained 2.91% of your investment in 2240 days.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics & genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. The Company has three product candidates in clinical development. It's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia & bipolar disorder & is in a Phase III clinical trial for schizophrenia. It's second product candidate, is a compound for the treatment of insomnia & depression which is currently in a Phase III clinical trial for insomnia. It's third product candidate, is a compound for the treatment of excessive sleepiness & is ready for a Phase II clinical trial.

Our focus on growing and mid-sized companies enables us to identify unique investment ideas, which can make the difference in a tough market. Jefferies' research effort covers U.S. & International equity, high yield, convertibles, investment grade fixed income and post-reorganization securities, as well as special situations and quantitative research. The more than 120-person team of research professionals covers over 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes and dig deeper to provide in-depth, thought provoking, objective research. Our analysts use a variety of quantitative and qualitative tools, integrating field analysis, proprietary channel checks and ongoing dialogue with the managements of the companies they cover. We utilize the latest technologies to deliver a research product that is timely, differentiated, and tailored to each customer's needs. Regular client access to companies and their management teams is provided through a wide variety of Jefferies hosted industry conferences, company management meetings and on-site tours.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/17/2010 11:25 AM Buy
None
10.88 20.00
as of 12/31/2010
1 Week down  -15.88 %
1 Month down  -0.12 %
3 Months up  20.50 %
1 YTD down  -28.44 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/9/2009 8:25 AM Buy
None
11.65 22.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy